SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹-5.96 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹16 Cr |
Mar2017 | ₹14 Cr |
Mar2016 | ₹24 Cr |
How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.96 Cr | Negative | |
Mar2023 | ₹11 Cr | -35.52 | |
Mar2022 | ₹16 Cr | 17.98 | |
Mar2017 | ₹14 Cr | -42.50 | |
Mar2016 | ₹24 Cr | - |
Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,045.4 Cr | -2.7% | 8.4% | 95.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,948.0 Cr | -0% | 0.5% | 46.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,873.0 Cr | -3% | 0.9% | 61.2% | Stock Analytics | |
CIPLA | ₹116,809.0 Cr | -2.1% | -6.9% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,963.0 Cr | -0.6% | -3.3% | 7.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,173.2 Cr | -1.9% | 0.7% | 54.5% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -2.7% |
8.4% |
95.3% |
SENSEX | -0.6% |
2.3% |
16.9% |
You may also like the below Video Courses